Shop
Checkout
CONFERENCES
REPORTS
MEDIA
PROFESSIONAL
EDUCATIONAL
CHI home
about
contact us
request information
Home
All Reports
How To Order
Affiliated Reports
About Us
Contact Us
Biosimilars & Generic Markets
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies
December 2012
Single User - $1,354.60
Single Site - $2,709.20
Multi Site - $4,063.80
Competitor Analysis: EGF-R Antibodies-Biosimilars and Biosuperiors
December 2012
Single User - $261.72
Single Site - $523.44
Multi Site - $785.16
Competitor Analysis: VEGF Antibodies - Bevacizumab and Ranibizumab Biosimilars and Biosuperiors
November 2012
Single User - $392.58
Single Site - $785.16
Multi Site - $1,177.74
Competitor Analysis: Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors
November 2012
Single User - $392.58
Single Site - $785.16
Multi Site - $1,177.74
Competitor Analysis: CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors
November 2012
Single User - $392.58
Single Site - $785.16
Multi Site - $1,177.74
Cell Culture - Rising Demand for Biologics and Growing Visibility of Approval Pathway for Biosimilars will Create Growth Opportunities
November 2012
Single User - $3,500.00
Single Site - $7,000.00
Multi Site - $10,500.00
Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
July 2012
Single User - $3,500.00
Single Site - $7,000.00
Multi Site - $10,500.00
Branded Generics in South East Asia: Current and Future Opportunities
April 2012
Single User - $1,495.00
Single Site - $5,235.00
Multi Site - $10,465.00
Generics as a Vehicle to Improve Market Access
April 2012
Single User - $695.00
Single Site - $3,475.00
Multi Site - $10,425.00
Generic Defence Strategies: Targeting Patient Co-Pay
March 2012
Single User - $695.00
Single Site - $3,475.00
Multi Site - $10,425.00
First
1
2
Last
ALL REPORTS
ALL REPORTS
2013
2012
2011
2010
2009
2008
2007
2006
2005
SERIES
Biological Therapeutic Products
Biomarkers & Diagnostics
BioPharma Strategy
Emerging and International Markets and Outsourcing:
Market Outlook, Strategies, Licensing and Mergers and Acquisitions
MSL-KOL
Outsourcing
Pharmaceutical Marketing
Resource Guides
Bioprocess & Manufacturing
Chemistry
Clinical Trials & Translational Medicine
Drug & Device Safety
Drug Discovery & Development
Biosimilars & Generic Markets
Imaging
Drug Targets
Genomics
Healthcare
IT & Informatics
Technology & Tools for Life Science
Therapeutic Indications
Adrenal Diseases
Alzheimer’s Disease
Anti-Viral and Therapeutics
Autoimmune Diseases and Therapeutics
Blood Disorders and Diseases
Cancer Research and Therapeutics
Cardiovascular
CNS
Diabetes
Epidemiology
Liver Diseases
Neurological Diseases and Therapeutics
Pain Management
Respiratory Disease and Therapeutics
Vaccines
Women’s Health